Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia

Archives of Gynecology and Obstetrics

Volumn 276, Issue 6, 2007, Pages 567-571

  Weintraub, Adi Y ^a   Sheiner, Eyal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anticoagulant therapy; Low molecular weight heparin; Thrombophilia; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; COUMARIN DERIVATIVE; DALTEPARIN; ENOXAPARIN; HEPARIN; HEPARIN DERIVATIVE; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE SULFATE; WARFARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; EMBOLISM; HEART VALVE PROSTHESIS; HUMAN; MEDLINE; PLACENTA DISORDER; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW; THROMBOPHILIA; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 35648930441     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-007-0409-2     Document Type: Review

References (38)

1. Weintraub AY, Press F, Wiztitzer A, Sheiner E (2007) Maternal thrombophilia and adverse pregnancy outcomes. Expert Rev Obstet Gynecol 2:203-216
2. Kupferminc MJ (2005) Thrombophilia and preeclampsia: the evidence so far. Clin Obstet Gynecol 48:406-415
3. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB (2000) Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 96:45-49
4. Dizon-Townson DS, Nelson LM, Easton K, Ward K (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175:902-905
5. Peeters LLH (2001) Thrombophilia and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 95:202-205
6. Preston FE, Rosendaal FR, Walker ID et al (1996) Increased fetal loss in women with heritable thrombophilia. Lancet 348:913-916
7. Rai R, Shelbak A, Cohen H et al (2001) Factor V Leiden and acquired protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16:961-965
8. Eldor A (2001) Thrombophilia, thrombosis and pregnancy. Thromb Haemost 86:104-111
9. Kupferminc MJ, Eldor A, Steinman N et al (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9-13
10. Weintraub AY, Sheiner E, Levy A, Yerushalmi R, Mazor M (2006) Pregnancy complications in women with inherited thrombophilia. Arch Gynecol Obstet 274:125-129
11. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM (2001) Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 185:153-157
12. Infante-Rivard C, Rivard GE, Yotov WV et al (2002) Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 347:19-25
13. McCowan LM, Craigie S, Taylor RS, Ward C, McLintock C, North RA (2003) Inherited thrombophilias are not increased in "idiopathic" small-for-gestational-age pregnancies. Am J Obstet Gynecol 188:981-985
14. Wu O, Robertson L, Twaddle S et al (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Health Technol Assess 10:1-110
15. Sheiner E, Levy A, Katz M, Mazor M (2005) Pregnancy outcome following recurrent spontaneous abortions. Eur J Obstet Gynecol Reprod Biol 118(1):61-65
16. Weintraub AY, Sheiner E, Bashiri A, Shoham-Vardi I, Mazor M (2005) Is there a higher prevalence of pregnancy complications in a live-birth preceding the appearance of recurrent abortions? Arch Gynecol Obstet 271:350-354
17. Greer I, Hunt BJ (2005) Low molecular weight heparin in pregnancy: current issues. Br J Haematol 128:593-601
18. De Santis M, Cavaliere AF, Straface G, Di Gianantonio E, Caruso A (2006) Inherited and acquired thrombophilia: pregnancy outcome and treatment. Reprod Toxicol 22:227-233
19. Bates SM (2002) Treatment and prophylaxis of venous thromboembolism during pregnancy. Thromb Res 108:97-106
20. Bates SM, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 26:627S-644S
21. Lepercq J, Conard J, Borel-Derlon A et al (2001) Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. Br J Obstet Gynaecol 108:1134-1140
22. Dolovich L, Ginsberg JS, Douketis JD et al (2000) A meta-analysis comparing low molecular weight heparins to unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 160:181-188
23. Gould MK, Dembitzer AD, Doyle RL et al (1999) Low molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med 130:800-809
24. Kupferminc MJ, Fait G, Many A et al (2001) Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 20:35-44
25. Brenner B, Bar J, Ellis M, Yarom I, Yohai D, Samueloff A (2005) Live-Enox. Investigators effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertil Steril 84:770-773
26. De Carolis S, Ferrazzani S, De Stefano V, Garofalo S, Fatigante G, Rossi E, Leone G, Caruso A (2006) Inherited thrombophilia: treatment during pregnancy. Fetal Diagn Ther 21:281-286
27. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J (2005) LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost 3:227-229
28. Grandone E, Brancaccio V, Colaizzo D et al (2002) Preventing adverse obstetric outcomes in women with genetic thrombophilia. Fertil Steril 78:371-375
29. Carp H, Dolitzky M, Inbal A (2003) Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 1:433-438
30. Gris JC, Mercier E, Quere I et al (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103:3695-3699
31. Chasen ST (2006) Peripartum and perioperative management of the anticoagulated patient. Obstet Gynecol Clin North Am 33:493-497
32. Sanson BJ, Lensing AW, Prins MH et al (1999) Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 81:668-672
33. Kupferminc MJ (2003) Thrombophilia and pregnancy. Reprod Biol Endocrinol 1:111
34. Greer IA (2003) Thrombophilia: implications for pregnancy outcome. Thromb Res 109:73-81
35. Dargaud Y, Rugeri L, Ninet J, Negrier C, Trzeciak MC (2005) Management of pregnant women with increased risk of venous thrombosis. Int J Gynaecol Obstet 90:203-207
36. Kupferminc MJ, Eldor A, Steinman N et al (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9-13
37. Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ (2001) Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstetric Gynecol 98:1041-1044
38. Anderson DR, Ginsberg JS, Burrows R, Brill-Edwards P (1991) Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb Haemost 65:248-250